FDA Seeks Feedback on Potential Regulatory Approaches for Generative AI-Enabled Medical Devices
The American Hospital Association reports that the FDA has issued a discussion paper detailing possible regulatory frameworks for generative AI-enabled medical devices. The document highlights considerations for risk classification, premarket review, and postmarket surveillance, and aims to catalyze broader stakeholder engagement around clinical AI governance and safety standards ahead of formal rulemaking.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.